CGEM logo

Cullinan Oncology (CGEM)

Profile

Full Name

Cullinan Therapeutics, Inc.

Ticker Symbol

CGEM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 8, 2021

Indexes

Not included

Website

http://cullinantherapeutics.com

Employees

111

Key Details

Price

$7.58(-2.70%)

Market cap

$443.53M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.78(+13.40% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.58
CGEM price is $7.58

30-Day Relative Volume

1.00
CGEM 30-day relative volume is 1.00

Price Performance

Price Today change

-2.7%
CGEM price is down -2.7% today

Price YTD change

-37.77%
CGEM price is down -37.77% since January 1st

Price 1-year change

-55.57%
CGEM price is down -55.57% year-on-year

Price 3-year change

-35.49%
CGEM price is down -35.49% over the past 3 years

Price Range

Price All-time high

$59.85
CGEM price is currently -87.34% below its historical high of $59.85

Price 3-year low

$6.85
CGEM price is currently +10.66% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$443.53M
CGEM market capitalization is $443.53 million

Market cap 3-year change

-15.48%
CGEM market capitalization is down -15.48% over the past 3 years

Market cap All-time high

$2.32B
CGEM market capitalization is currently -80.92% below its historical high of $2.32 billion

Market cap sector rank

68.45%
CGEM market capitalization is higher than 68.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+35.87%
CGEM shares outstanding is up +35.87% year-on-year

Shares Outstanding 3-Year Change

+31.02%
CGEM shares outstanding is up +31.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.97
CGEM beta is 0.97

200-day SMA

$13.79
CGEM price is currently -45.04% below its 200-day simple moving average

50-day SMA

$8.79
CGEM price is currently -13.76% below its 50-day simple moving average

RSI

40.20
CGEM 14-day relative strength index is 40.20

Volume

1.00
CGEM 30-day relative volume is 1.00

ATR

$0.54
CGEM average true range is $0.54

10-day Historical Volatility

59.72%
CGEM 10-day historical volatility is 59.72%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CGEM annual revenue value is unknown

Revenue Analysts estimate

$7.22M
CGEM annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
CGEM annual revenue 1-year change is unknown

Revenue Sector rank

-
CGEM annual revenue is unknown

EPS

EPS

-$2.78
CGEM annual earnings per share is -$2.78

EPS Analysts estimate

-$3.36
CGEM annual earnings per share is currently -17.31% lower than the consensus analysts' forecast

EPS 1-year change

+13.4%
CGEM annual earnings per share is up +13.4% year-on-year

EPS Sector rank

31.46%
CGEM annual earnings per share is higher than 31.46% of companies in Healthcare sector

Profit

Gross profit

-
CGEM annual gross profit value is unknown

Gross margin

-
CGEM annual gross profit margin value is unknown

Operating profit

-$196.92M
CGEM annual operating income is -$196.92 million

Operating margin

-
CGEM annual operating profit margin value is unknown

Net income

-$167.38M
CGEM annual net profit is -$167.38 million

Net margin

-
CGEM annual net profit margin value is unknown

Expenses

Total expenses

$196.92M
CGEM annual total expenses is $196.92 million

Operating expenses

$196.92M
CGEM annual total operating expenses is $196.92 million

Cost of goods sold

-
CGEM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$54.02M
CGEM annual SGA is $54.02 million

Depreciation and amortization

$306.00K
CGEM annual depreciation & amortization is $306.00 thousand

Interest expense

-
CGEM annual interest expense value is unknown

Income tax

$117.00K
CGEM annual income tax is $117.00 thousand

EBIT & EBITDA

EBIT

-$196.92M
CGEM annual earnings before interest & taxes is -$196.92 million

EBITDA

-$196.61M
CGEM annual EBITDA is -$196.61 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$621.82M
CGEM annual total assets is $621.82 million

Non current assets

$207.16M
CGEM annual long term assets is $207.16 million

Current assets

$414.67M
CGEM annual total current assets is $414.67 million

Cash and cash equivalents

$83.00M
CGEM annual cash & cash equivalents is $83.00 million

Accounts receivable

-
CGEM annual accounts receivable value is unknown

Inventory

-
CGEM annual inventory value is unknown

Liabilities

Total liabilities

$31.50M
CGEM annual total liabilities is $31.50 million

Long term liabilities

$849.00K
CGEM annual total long term liabilities is $849.00 thousand

Current liabilities

$30.65M
CGEM annual total current liabilities is $30.65 million

Accounts payable

$1.68M
CGEM annual accounts payable is $1.68 million

Debt

Total debt

$2.15M
CGEM annual total debt is $2.15 million

Total debt 1-year change

-40.08%
CGEM annual total debt is down -40.08% year-on-year

Long term debt

$849.00K
CGEM annual long term debt is $849.00 thousand

Short term debt

$1.30M
CGEM annual short term debt is $1.30 million

Equity & Capital

Shareholders equity

$590.33M
CGEM annual stockholders equity is $590.33 million

Book value

$590.33M
CGEM annual book value is $590.33 million

Retained earnings

-$368.24M
CGEM annual retained earnings is -$368.24 million

Working capital

$384.02M
CGEM annual working capital is $384.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$145.30M
CGEM annual cash flow from operations is -$145.30 million

Cash from operations 1-year change

-8.21%
CGEM annual cash flow from operations is down -8.21% year-on-year

Cash from investing

-$136.31M
CGEM annual cash flow from investing activities is -$136.31 million

Cash from investing 1-year change

-480.7%
CGEM annual cash flow from investing activities is down -480.7% year-on-year

Cash from financing

$266.19M
CGEM annual cash flow from financing activities is $266.19 million

Cash from financing 1-year change

+553.21%
CGEM annual cash flow from financing activities is up +553.21% year-on-year

CAPEX

CAPEX

-
CGEM annual capital expenditures value is unknown

CAPEX 1-year change

-
CGEM annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$145.30M
CGEM annual free cash flow is -$145.30 million

Free cash flow 1-year change

-8.05%
CGEM annual free cash flow is down -8.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CGEM annual gross profit margin value is unknown

Operating margin

-
CGEM annual operating profit margin value is unknown

Net margin

-
CGEM annual net profit margin value is unknown

ROA & ROE

ROA

-26.92%
CGEM annual return on assets is -26.92%

ROE

-28.35%
CGEM annual return on equity is -28.35%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CGEM price to earnings ratio value is unknown

PE ratio Sector rank

-
CGEM price to earnings ratio is unknown

PB Ratio

PB ratio

0.75
CGEM price to book ratio is 0.75

PB ratio Sector rank

39.39%
CGEM price to book ratio is higher than 39.39% of companies in Healthcare sector

PS Ratio

PS ratio

-
CGEM price to sales ratio value is unknown

PS ratio Sector rank

-
CGEM price to sales ratio is unknown

Enterprise value

Enterprise value

$362.67M
CGEM enterprise value is $362.67 million

Enterprise value Sector rank

66.45%
CGEM enterprise value is higher than 66.45% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.84
CGEM EV/EBITDA is -1.84

EV/EBITDA Sector rank

32.29%
CGEM EV/EBITDA is higher than 32.29% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

13.53
CGEM annual current ratio is 13.53

Quick ratio

-
CGEM annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CGEM annual debt to equity ratio is 0.00

Interest coverage ratio

-
CGEM annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CGEM piotroski f-score value is unknown

Altman Z-Score

-
CGEM altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 28, 25 HC Wainwright & Co.
Buy
Oct 24, 24 UBS
Buy
Aug 9, 24 Wedbush
Outperform
Jun 3, 24 HC Wainwright & Co.
Buy
May 24, 24 HC Wainwright & Co.
Buy
May 16, 24 Wedbush
Outperform
May 16, 24 HC Wainwright & Co.
Buy
May 1, 24 Stifel
Buy
Apr 17, 24 JonesTrading
Buy
Apr 17, 24 BTIG
Buy

Institutional Ownership

Similar stocks

CRMD logo
CorMedix (CRMD)
Beta Bionics (BBNX)
MDRX logo
Veradigm (MDRX)
ARVN logo
Arvinas (ARVN)
TMCI logo
Treace Medical Concepts (TMCI)
SVA logo
Sinovac Biotech (SVA)
URGN logo
UroGen Pharma (URGN)
AKBA logo
Akebia Therapeutics (AKBA)
CDXC logo
ChromaDex (CDXC)
  • What is the ticker symbol for Cullinan Oncology?
  • Does Cullinan Oncology pay dividends?
  • What sector is Cullinan Oncology in?
  • What industry is Cullinan Oncology in?
  • What country is Cullinan Oncology based in?
  • When did Cullinan Oncology go public?
  • Is Cullinan Oncology in the S&P 500?
  • Is Cullinan Oncology in the NASDAQ 100?
  • Is Cullinan Oncology in the Dow Jones?
  • When was Cullinan Oncology's last earnings report?
  • When does Cullinan Oncology report earnings?
  • Should I buy Cullinan Oncology stock now?

What is the ticker symbol for Cullinan Oncology?

The ticker symbol for Cullinan Oncology is NASDAQ:CGEM

Does Cullinan Oncology pay dividends?

No, Cullinan Oncology does not pay dividends

What sector is Cullinan Oncology in?

Cullinan Oncology is in the Healthcare sector

What industry is Cullinan Oncology in?

Cullinan Oncology is in the Biotechnology industry

What country is Cullinan Oncology based in?

Cullinan Oncology is headquartered in United States

When did Cullinan Oncology go public?

Cullinan Oncology's initial public offering (IPO) was on January 8, 2021

Is Cullinan Oncology in the S&P 500?

No, Cullinan Oncology is not included in the S&P 500 index

Is Cullinan Oncology in the NASDAQ 100?

No, Cullinan Oncology is not included in the NASDAQ 100 index

Is Cullinan Oncology in the Dow Jones?

No, Cullinan Oncology is not included in the Dow Jones index

When was Cullinan Oncology's last earnings report?

Cullinan Oncology's most recent earnings report was on Feb 27, 2025

When does Cullinan Oncology report earnings?

The next expected earnings date for Cullinan Oncology is May 15, 2025

Should I buy Cullinan Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page